arrow
V

Vladimir Chulanov

Russian Academy of Sciences
H指数:31
被引数:6,764

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and posttreatment results from a Phase 3 randomized trial

144周布罗维特德单药治疗慢性丁型肝炎:一项III期随机试验的最终和治疗后结果

2026-04-090
PRE
Saponin is Essential for the Isolation of Proteins and RNA from Biological Nanoparticles
2024-10-140
PRE
Biomimetic Nanoparticles for Basic Drug Delivery
2024-10-074
OAAI
Bulevirtide monotherapy in patients with chronic HDV : Efficacy and safety results through week 96 from a phase III randomized trial
2024-10-015
OAAI
Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study
2024-10-010
PRE
Swelling, Rupture and Endosomal Escape of Biological Nanoparticles Per Se and Those Fused with Liposomes in Acidic Environment
2024-05-166
OAAI
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
2024-04-0118
PRE
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
2023-07-0680
OA